Nutrilite Memory Builder on the Improvement of Cognitive Function
NCT05591885, Not applicable, Unknown, Amway (China) R&D Center
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Nutrilite Memory Builder on the Improvement of Cognitive Function | ClinicalTrials.gov |
| NCT number | NCT05591885 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 100 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Amway (China) R&D Center | ClinicalTrials.gov |
| Conditions | Cognitive Function | ClinicalTrials.gov |
| Interventions | Study product group (Nutrilite Memory Builder), Placebo group | ClinicalTrials.gov |
| First posted | 2022-10-24 | ClinicalTrials.gov |
| Last updated | 2023-04-28 | ClinicalTrials.gov |
Registered outcomes 16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Mini-Mental State Examination | endpoint( day 90) | Change of mental status after 90-days product intervention | ClinicalTrials.gov |
| Primary | Wechsler Memory Scale RC | endpoint( day 90) | Change of memory after 90-days product intervention. A complete set of memory evaluation tools with 10 subscales measured three aspects of participants' long-term, short-term and instantaneous memory, which added three sub-tests to WMS. Among them, there are 3 sub-tests of long-term memory, namely personal experience, orientation, and numerical order; There are 6 sub-tests for short-term memory, namely visual rerecognition, picture recall, visual regeneration, associative learning, touch, and comprehension; Instantaneous memory has only 1 sub-test, i.e. reciting numbers in a forward and backward manner. Scoring uses the Memory Quotient (MQ) method, where higher MQ values indicate better memory ability. | ClinicalTrials.gov |
| Secondary | Quality of Life Scale | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Record the data of the subjects' life quality,The quality score is 60 points, the good is 51-60 points, the good is 41-50 points, the general is 31-40 points, the poor is 21-30 points, and the quality of life is \< 20 points. | ClinicalTrials.gov |
| Secondary | Activities of Daily Living Scale | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Record the data of the subjects' activities of daily living；The scoring results can be divided into four grades: grade 0=self-care: 100 points, good ability of daily living activities, without help from others grade=mild dysfunction: 99-61 points, able to independently complete some daily activities, but need help; Level II=moderate dysfunction: 60-41 points, need great help to complete activities of daily living Level III=severe dysfunction: ≤ 40 points, most activities of daily living can not be completed completely need care. | ClinicalTrials.gov |
| Secondary | Verbal Memory Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' verbal memory | ClinicalTrials.gov |
| Secondary | Finger Tapping Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' finger movement | ClinicalTrials.gov |
| Secondary | Symbol Digit Coding Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' processing speed, working memory, visuospatial processing, and attention. | ClinicalTrials.gov |
| Secondary | Stroop Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' memory and attention. | ClinicalTrials.gov |
| Secondary | Shifting Attention Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' measures the subject s ability to shift from one instruction set to another quickly and accurately. | ClinicalTrials.gov |
| Secondary | Continuous Performance Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' different aspects of attention. | ClinicalTrials.gov |
| Secondary | Four-part Continuous Performance Test of Cognitrax Test | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Use the official website(www.cnsvs.com) to test subjects' cognitive ability. | ClinicalTrials.gov |
| Secondary | Montreal Cognitive Assessment; | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Test Cognitive Ability | ClinicalTrials.gov |
| Secondary | 72-hrs Food Recall | baseline(day 0)/interim ( day 45)/endpoint( day 90) | 72-hours food recall of subjects | ClinicalTrials.gov |
| Secondary | Sport Frequency Questionnaire | baseline(day 0)/interim ( day 45)/endpoint( day 90) | Record the exercise frequency and duration within one week, without any score. | ClinicalTrials.gov |
| Secondary | Blood | baseline(day 0)/endpoint( day 90) | blood routine test （red blood cell count, white blood cell count, platelet count，hemoglobin） | ClinicalTrials.gov |
| Secondary | Urine | baseline(day 0)/endpoint( day 90) | Urine routine test（Leukocyte, Urine Protein, Ketone Body） | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Continuous Performance Test | Secondary outcome | ConductCognition |
| Finger Tapping Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)